focus -WSS

focus

author：explore 2025-09-30 12:11:28 - browse：6

ASH19 CAR-T — Victor Segura Ibarra and Rita Serda, Ph.D., NCI, NIH

The Food and Drug Administration on Wednesday approved a futuristic new approach to treating cancer, clearing a Novartis therapy that has produced unprecedented results in patients with a rare and deadly cancer. The price tag: $475,000 for a course of treatment.

That sounds staggering to many patients — but it’s far less than analysts expected.

The therapy, called a CAR-T, is made by harvesting patients’ white blood cells and rewiring them to home in on tumors. Novartis’s product is the first CAR-T therapy to come before the FDA, leading a pack of novel treatments that promise to change the standard of care for certain aggressive blood cancers.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： How to save PrEP access — and even expand it
Next article： Readout Newsletter: Illumina, CRISPR, Regeneron

WSS

6 surprising facts about sugar

Pancreatic cancer early detection could be helped by AI

'Patient friction coefficient' can gauge a clinical trial's patient burden

10 reasons why health care startups fail

U.K. officials, researchers try to ease path for bespoke genetic treatments

Health Care Service Corp to buy Cigna Medicare Advantage plans

focus

focus

entertainment

The cancer drug shortage isn’t new — and neither are the solutions

Steward Health Care expansion into Malta flopped

Psychedelics group wrestles with new pharma identity

Reconstructing family trees of blood cells may help predict disease

Virginia high school admissions case could be legal follow

Readout LOUD podcast, live from the STAT Breakthrough Summit East

As demand for Covid shots wanes, Moderna seeks its next success

Pregnancy ages women, but effects reverse after delivery

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Merck CEO won’t testify in Senate, citing no expertise in drug prices

focus

Syphilis numbers in the United States reach record heights

FTC sues over Novant Health acquisition of two N.C. hospitals

Bernie Sanders is gearing up to subpoena pharma CEOs

Pancreatic cancer early detection could be helped by AI

Reconstructing family trees of blood cells may help predict disease

The latest on Bluebird gene therapies, Vertex's pain drug, and ADC FOMO

knowledge

focus

knowledge

knowledge